Oncternal Therapeutics, Inc. reports

Company location: San Diego, CA
Fiscal year end: 31 December

Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 176-200 of 1,000 matching filings.

Per page

25

Current page

8

4

FORM 4 SUBMISSION

Filing date: 24 Jan 2022
Reporting date: 20 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 24 Jan 2022
Reporting date: 20 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 24 Jan 2022
Reporting date: 20 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 24 Jan 2022
Reporting date: 20 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jan 2022
Reporting date: 03 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 17 Dec 2021
Reporting date: 17 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B5 File 333-254985

424B5

Filing date: 17 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 13 Dec 2021
Reporting date: 13 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 000-50549

10-Q

Filing date: 04 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 04 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 000-50549

10-Q

Filing date: 05 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 05 Aug 2021
Reporting date: 05 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Jul 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 21 Jun 2021
Reporting date: 18 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2021
Reporting date: 11 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-254985

424B5

Filing date: 28 May 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 28 May 2021
Reporting date: 25 May 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 May 2021
Reporting date: 25 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 May 2021
Reporting date: 25 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 27 May 2021
Reporting date: 25 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .